Your session is about to expire
← Back to Search
Device
Surveillance Monitoring as an Alternative to Telemetry
N/A
Waitlist Available
Led By Stacey House, MD, PhD
Research Sponsored by Medtronic - MITG
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to end of hospital stay (or up to 30 day post enrollment)
Awards & highlights
No Placebo-Only Group
Summary
The purpose of the study is to evaluate the impact of surveillance monitoring versus telemetry monitoring on clinical, healthcare economics, resource utilization, and qualitative outcomes.
Eligible Conditions
- Patient Monitoring
- Telemetry
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to end of hospital stay (or up to 30 day post enrollment)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to end of hospital stay (or up to 30 day post enrollment)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Hospital Length of Stay (LOS) as Assessed by Review of Medical Records
Secondary study objectives
Associated Health Care Costs (HCC) as Determined by Review of Billing Records
Clinical Team and Patient Satisfaction as Measured by Qualitative Questionnaires
Clinicians Familiarity With AHA Guidelines and Telemetry Utilization as Measured by Qualitative Questionnaires
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Surveillance Monitoring ArmExperimental Treatment1 Intervention
Subjects in the surveillance monitoring group will alternatively be admitted to medical surgical unit and be monitored via the surveillance monitoring platform.
Group II: Telemetry Monitoring ArmActive Control1 Intervention
The telemetry group will serve as the control group and will be monitored via the site's standard of care telemetry protocols.
Find a Location
Who is running the clinical trial?
Medtronic - MITGLead Sponsor
263 Previous Clinical Trials
300,682 Total Patients Enrolled
Stacey House, MD, PhDPrincipal InvestigatorWashington University in Saint Louis